Biopharma Analyst Chen, along with JNJ‘s President Naumovic, US Solid Tumor-Oncology, VP-Medical Affairs Oncology Wildgust, discuss takeaways from ESMO & WCLC on a conference call. to be held on September 20 at 2 pm. Webcast Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- AC Immune receives second milestone payment for ACI-35.030
- J&J data presents ‘limited downside’ to CG Oncology, says Goldman Sachs
- Johnson & Johnson announces interim data from SunRISe-4 study
- J&J announces additional results from pivotal Phase 2b SunRISe-1 study
- Johnson & Johnson announces new data from Phase 1b/2 OrigAMI-1 study